|
Getting your Trinity Audio player ready...
|
South Carolina’s Comptroller General – From Bookkeeper to Watchdog
Mike Burkhold: “If a company’s CFO treated fraud or misallocation as ‘clerical errors,’ they’d be fired on the spot. Why should taxpayers accept anything less?”
7 comments
Great article! We should all vote for this guy! ?
This guy sounds exactly what we need.
Best wishes for a successful race.
Why have the functions of this office never come to the voters’ attention? Many of us have asked the question, “where are our tax dollars going?” This is an excellent opportunity for the citizens of SC to become aware of how our money is being spent. Let’s give Mike our vote for change.
According to Grok, the yearly average of total tax revenue increase for the state over the last decade is 5.4%. So if spending is growing by an average of 6.9% per year, the net spending increase over the increase in revenue is 1.5%. And, despite that residual increase, our surplus reserves are huge, so that 1,5% is not unfunded or causes us to have to resort to borrowing, or increasing taxes. While we would all like greater transparency and lower taxes and spending, in terms of overall fiscal responsibility our state actually does quite well – hence SC being one of only 7 or 8 states with at least two triple A credit ratings in the nation.
I fully and energetically support Mike Burkhold. He will be focused on protecting the interests of South Carolina taxpayers. I believe the election for SC Comptroller General this year is critical.
If elected are he and his family going to relocate to the Columbia area? We don’t need another elected official who is in the office part time. Will he disclose all his personal investments and the investments and contracts his company holds?
According to online information “Equiscript helps high-risk, high-need patients get the medications they need while also generating revenue to support community health centers and hospitals. We do this by managing 340B home delivery pharmacy programs on behalf of hospitals and health centers across the U.S.”
And “Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients. These organizations include federal grantee organizations and several types of hospitals, including critical access hospitals (CAHs), sole community hospitals (SCHs), rural referral centers (RRCs), and public and nonprofit disproportionate share hospitals (DSH) that serve low-income and indigent populations. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients and expand health services to the patients and communities they serve. Hospitals use 340B savings to provide, for example, free care for uninsured patients, offer free vaccines, provide services in mental health clinics, and implement medication management and community health programs.”